Jon Chesto — Boston Globe

BioTech

Biogen CEO tells Mass. governor he’s concerned about ‘a lot more policy risk’ in D.C.

Running a biotech company means taking risks — deciding where to invest, for example, or what scientific targets to chase. However, the sector faces another

Jon Chesto — Boston Globe January 24, 2025

BioTech

Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical

Jon Chesto — Boston Globe November 13, 2024

BioTech

For-profit health system’s Mass. hospitals teetering on the brink of financial disaster

Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a

Jon Chesto — Boston Globe March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Jon Chesto — Boston Globe

Biogen CEO tells Mass. governor he’s concerned about ‘a lot more policy risk’ in D.C.

Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

For-profit health system’s Mass. hospitals teetering on the brink of financial disaster

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe